Perfuse Therapeutics
San Francisco
About Perfuse Therapeutics
Perfuse Therapeutics specializes in developing therapies for the treatment of eye disease. The company is pursuing a novel mechanism to treat various eye diseases, starting with glaucoma, by improving retinal perfusion.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2020)
- Website: perfusetherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/perfuse-therapeutics-117775 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.